HRP20020220A2 - Thienoisoxazolyl- and thienilpyrrazolyl-phenoxy substituted propyl derivatives useful as d4 antagonists - Google Patents

Thienoisoxazolyl- and thienilpyrrazolyl-phenoxy substituted propyl derivatives useful as d4 antagonists Download PDF

Info

Publication number
HRP20020220A2
HRP20020220A2 HR20020220A HRP20020220A HRP20020220A2 HR P20020220 A2 HRP20020220 A2 HR P20020220A2 HR 20020220 A HR20020220 A HR 20020220A HR P20020220 A HRP20020220 A HR P20020220A HR P20020220 A2 HRP20020220 A2 HR P20020220A2
Authority
HR
Croatia
Prior art keywords
thieno
compound according
phenoxy
isoxazol
propan
Prior art date
Application number
HR20020220A
Other languages
English (en)
Croatian (hr)
Inventor
David M Fink
Brian S Freed
Nicholas J Hrib
Raymond W Kosley Jr
Georg E Lee
Gregory H Merriman
Barbara S Rauckman
Original Assignee
Aventis Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharmaceuticals filed Critical Aventis Pharmaceuticals
Publication of HRP20020220A2 publication Critical patent/HRP20020220A2/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
HR20020220A 1999-09-14 2000-09-13 Thienoisoxazolyl- and thienilpyrrazolyl-phenoxy substituted propyl derivatives useful as d4 antagonists HRP20020220A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39608199A 1999-09-14 1999-09-14
PCT/US2000/024962 WO2001019833A1 (en) 1999-09-14 2000-09-13 Thienoisoxazolyl- and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as d4 antagonists

Publications (1)

Publication Number Publication Date
HRP20020220A2 true HRP20020220A2 (en) 2004-02-29

Family

ID=23565772

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20020220A HRP20020220A2 (en) 1999-09-14 2000-09-13 Thienoisoxazolyl- and thienilpyrrazolyl-phenoxy substituted propyl derivatives useful as d4 antagonists

Country Status (26)

Country Link
EP (1) EP1216250B1 (cs)
JP (1) JP4847662B2 (cs)
KR (1) KR20020027647A (cs)
AR (1) AR032134A1 (cs)
AT (1) ATE254621T1 (cs)
AU (1) AU7577400A (cs)
BR (1) BR0014515A (cs)
CA (1) CA2383340C (cs)
CY (1) CY1101692T1 (cs)
CZ (1) CZ2002897A3 (cs)
DE (1) DE60006699T2 (cs)
DK (1) DK1216250T3 (cs)
EA (1) EA200200355A1 (cs)
EE (1) EE200200135A (cs)
ES (1) ES2209995T3 (cs)
HR (1) HRP20020220A2 (cs)
HU (1) HUP0203526A3 (cs)
IL (1) IL148623A0 (cs)
MX (1) MXPA02002695A (cs)
NO (1) NO20021251L (cs)
PL (1) PL354515A1 (cs)
PT (1) PT1216250E (cs)
SK (1) SK3512002A3 (cs)
TW (1) TW530060B (cs)
WO (1) WO2001019833A1 (cs)
ZA (1) ZA200201762B (cs)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7091199B1 (en) 1999-09-14 2006-08-15 Aventis Pharmaceuticals Inc. Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists
US7253165B2 (en) 1999-09-14 2007-08-07 Aventis Pharmaceuticals Inc. Benzisoxazolyl-, pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D4 antagonists
US7125903B1 (en) 1999-09-14 2006-10-24 Aventis Pharmaceuticals Inc. Thienoisoxazolyl-and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as D4 antagonists
JP4497815B2 (ja) * 2001-02-16 2010-07-07 アベンティス・ファーマスーティカルズ・インコーポレイテツド 新規な複素環式アミド誘導体およびドーパミンｄ３受容体リガンドとしてのその使用
CN1300116C (zh) 2001-04-16 2007-02-14 卫材株式会社 1h－吲唑化合物
KR20040020457A (ko) * 2002-08-30 2004-03-09 주식회사 대웅 3-｛2-[4-(6-플루오로벤조[ｄ]이속사졸-3-일)피페리디노]에틸｝-2-메틸-6,7,8,9-테트라하이드로-4Ｈ-피리도[1,2-ａ]피리미딘-4-온 또는 그 산부가염의 제조방법
KR20050092424A (ko) * 2003-01-17 2005-09-21 씨브이 쎄러퓨틱스, 인코포레이티드 심혈관 질환의 치료에 유용한 치환된 헤테로고리 화합물
JP2007297321A (ja) * 2006-04-28 2007-11-15 Daiso Co Ltd アリール２−メチルグリシジルエーテル類の製造法
JP2007297330A (ja) * 2006-04-28 2007-11-15 Daiso Co Ltd ２−メチルグリシジル誘導体の製造法
CA2894126A1 (en) * 2012-12-21 2014-06-26 Epizyme, Inc. Prmt5 inhibitors and uses thereof
DK2935222T3 (en) 2012-12-21 2019-01-07 Epizyme Inc PRMT5 INHIBITORS AND APPLICATIONS THEREOF
JP2016505597A (ja) 2012-12-21 2016-02-25 エピザイム，インコーポレイティド Ｐｒｍｔ５阻害剤およびその使用
CA2899363A1 (en) 2012-12-21 2014-06-26 Epizyme, Inc. Prmt5 inhibitors and uses thereof
US9745291B2 (en) 2012-12-21 2017-08-29 Epizyme, Inc. PRMT5 inhibitors containing a dihydro- or tetrahydroisoquinoline and uses thereof
US20170198006A1 (en) * 2014-06-25 2017-07-13 Epizyme, Inc. Prmt5 inhibitors and uses thereof
WO2016022605A1 (en) 2014-08-04 2016-02-11 Epizyme, Inc. Prmt5 inhibitors and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4728651A (en) * 1985-10-24 1988-03-01 Hoechst-Roussel Pharmaceuticals Inc. Antihypertensive thieno-isoxazoles and -pyrazoles
US6187774B1 (en) * 1996-03-04 2001-02-13 Yoshitomi Pharmaceutical Industries, Ltd. Fused heterocyclic compounds and pharmaceutical applications thereof
HUP9603001A3 (en) * 1996-10-30 1999-07-28 Richter Gedeon Vegyeszet Heterocycle compounds comprising nitrogen, process for producing them and pharmaceutical compositions containing the same
JP4627882B2 (ja) * 1998-02-09 2011-02-09 デユフアー・インターナシヨナル・リサーチ・ベー・ブイ Ｄ４−アンタゴニスト活性を有するベンズイソキサゾール誘導体

Also Published As

Publication number Publication date
CA2383340C (en) 2010-06-15
ES2209995T3 (es) 2004-07-01
EE200200135A (et) 2003-04-15
TW530060B (en) 2003-05-01
NO20021251L (no) 2002-05-10
BR0014515A (pt) 2002-06-25
CZ2002897A3 (cs) 2002-07-17
DE60006699D1 (en) 2003-12-24
PL354515A1 (en) 2004-01-26
IL148623A0 (en) 2002-09-12
JP2003509432A (ja) 2003-03-11
KR20020027647A (ko) 2002-04-13
PT1216250E (pt) 2004-04-30
CA2383340A1 (en) 2001-03-22
JP4847662B2 (ja) 2011-12-28
ZA200201762B (en) 2003-08-27
DE60006699T2 (de) 2004-09-30
HUP0203526A3 (en) 2004-12-28
HUP0203526A2 (hu) 2003-01-28
WO2001019833A1 (en) 2001-03-22
CY1101692T1 (el) 2010-07-28
SK3512002A3 (en) 2003-03-04
EP1216250A1 (en) 2002-06-26
AU7577400A (en) 2001-04-17
DK1216250T3 (da) 2004-02-23
EA200200355A1 (ru) 2002-10-31
MXPA02002695A (es) 2002-07-30
EP1216250B1 (en) 2003-11-19
ATE254621T1 (de) 2003-12-15
NO20021251D0 (no) 2002-03-13
AR032134A1 (es) 2003-10-29

Similar Documents

Publication Publication Date Title
HRP20020220A2 (en) Thienoisoxazolyl- and thienilpyrrazolyl-phenoxy substituted propyl derivatives useful as d4 antagonists
JP4995203B2 (ja) 精神病および神経変性障害の処置のための、ｎ−ＡＣｈＲのコリン作動性リガンドとしての（１−アザ−ビシクロ［３．３．１］ノン−４−イル）−［５−（１Ｈ−インドール−５−イル）−ヘテロアリール］−アミン
JP6267334B2 (ja) ５−ｈｔ６拮抗薬としてのピロロキノリン誘導体、それらの製造方法および使用
EP1216244B1 (en) Benzisoxazolyl-, pyridoisoxazolyl- and benzthienyl-phenoxy derivatives useful as D4 antagonists
US7125903B1 (en) Thienoisoxazolyl-and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as D4 antagonists
US7253165B2 (en) Benzisoxazolyl-, pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D4 antagonists
JP3727569B2 (ja) テトラヒドロキナゾリン−２，４−ジオンおよびそれらの治療用途
WO2006051410A1 (en) Azabenzoxazoles for the treatment of cns disorders
EP1216249B1 (en) Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists
US7091199B1 (en) Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists
JPH09263587A (ja) 環状化合物、その製造法および剤

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20040826

Year of fee payment: 5

OBST Application withdrawn